Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study

More on Dementia

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Early statin use links to lower dementia risk in diabetes

  The Lancet Regional Health Europe · 4 Oct 2026

  

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026